The safety, tolerability, and effectiveness of PTL-101, an oral cannabidiol formulation, in pediatric intractable epilepsy: A phase II, open-label, single-center study.

CONCLUSIONS: PTL-101 was safe and tolerable for use and demonstrated a potent seizure-reducing effect among pediatric patients with TRE. PMID: 31394352 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31394352?dopt=Abstract

Source: Epilepsy and Behaviour - August 4, 2019 Category: Neurology Authors: Mitelpunkt A, Kramer U, Hausman Kedem M, Zilbershot Fink E, Orbach R, Chernuha V, Fattal-Valevski A, Deutsch L, Heffetz D, Sacks H Tags: Epilepsy Behav Source Type: research